I have 19 years of experience and specialize in the field of health economics, with specific knowledge of pharmaceutical pricing and reimbursement, economic evaluation and outcomes research. I have published on such topics as statin therapy, guidelines of economic evaluation of drugs and pharmaceutical regulation. I have testified on economic evaluation of pharmaceuticals, hospital finance and health policy.